Cornelis N. de Jong

Posttransplant cyclophosphamide for prevention of graft-versus-host disease: results of the prospective randomized HOVON-96 trial

Annoek E. C. Broers, Cornelis N. de Jong, Katerina Bakunina et al. · Blood Advances · 2022 · 105 citations · Full text

Post-Transplantation Cyclophosphamide after Allogeneic Hematopoietic Stem Cell Transplantation: Results of the Prospective Randomized HOVON-96 Trial in Recipients of Matched Related and Unrelated Donors

Cornelis N. de Jong, Ellen Meijer, Katerina Bakunina et al. · Blood · 2019 · 46 citations

Baseline Renal Function and Albumin are Powerful Predictors for Allogeneic Transplantation-Related Mortality

Roni Shouval, Cornelis N. de Jong, Joshua Fein et al. · Biology of Blood and Marrow Transplantation · 2018 · 31 citations · Full text

Solid Organ Transplantation, Renal Pathology, Transplantation Medicine +16

Etanercept for steroid-refractory acute graft-versus-host disease: A single center experience

Cornelis N. de Jong, Lotte Saes, Clara Klerk et al. · PLoS ONE · 2017 · 29 citations · Full text

Prospective evaluation of sequential treatment of sclerotic chronic graft versus host disease with rituximab and nilotinib

Lotte van der Wagen, Liane te Boome, Marleen Schiffler et al. · Bone Marrow Transplantation · 2018 · 16 citations

Transplantation, Systemic Scleroderma, Pathology +7